Bent Laursen Ejlertsen

Bent Laursen Ejlertsen

Clinical Professor

Member of:

  • Clinical Oncology


Publication year:
All
1 - 8 out of 8Page size: 10
  1. 2009
  2. Published

    Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

    Hansen, Thomas van Overeem, Jønson, L., Albrechtsen, Anders, Andersen, M. K., Ejlertsen, Bent Laursen & Nielsen, Finn Cilius, May 2009, In: Breast Cancer Research and Treatment. 115, 2, p. 315-323 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A common Greenlandic Inuit BRCA1 RING domain founder mutation

    Hansen, T. V. O., Ejlertsen, Bent Laursen, Albrechtsen, Anders, Bergsten, E., Bjerregaard, P., Hansen, T., Myrhoj, T., Nielsen, P. B., Timmermans-Wielenga, V., Andersen, M. K., Jonson, L. & Nielsen, F. C., 2009, In: Breast Cancer Research and Treatment. 115, 1, p. 69-76 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    A high frequent BRCA1 founder mutation identified in the Greenlandic population

    Harboe, T. L., Eiberg, Hans Rudolf Lytchoff, Kern, P., Ejlertsen, Bent Laursen, Nedergaard, L., Timmermans-Wielenga, V., Nielsen, I. & Bisgaard, M. L., 2009, In: Familial Cancer. 8, 4, p. 413-9 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer

    Henriksen, K. L., Rasmussen, B. B., Lykkesfeldt, A. E., Møller, S., Ejlertsen, Bent Laursen & Mouridsen, H. T., 2009, In: Acta Odontologica Scandinavica. 48, 4, p. 522-31 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

    Lykkesfeldt, A. E., Henriksen, K. L., Rasmussen, B. B., Sasano, H., Evans, D. B., Møller, S., Ejlertsen, Bent Laursen & Mouridsen, H. T., 2009, In: BMC Cancer. 9, p. 185

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Lack of TIMP-1 tumour cell immunoreactivity predicts effect of adjuvant anthracycline-based chemotherapy in patients (n=647) with primary breast cancer: A Danish Breast Cancer Cooperative Group Study

    Willemoe, G. L., Hertel, P. B., Bartels, Annette Snejbjerg, Jensen, M., Balslev, E., Rasmussen, B. B., Mouridsen, H. T., Ejlertsen, Bent Laursen & Brunner, N., 2009, In: European Journal of Cancer. 45, 14, p. 2528-2536 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer

    Ejlertsen, Bent Laursen, Jensen, M., Rank, F., Rasmussen, B. B., Christiansen, P., Kroman, Niels Thorndahl, Kvistgaard, M. E., Overgaard, M., Toftdahl, D. B., Mouridsen, H. T. & Danish Breast Cancer Cooperative Group, D. B. C. C. G., 2009, In: JNCI - Journal of the National Cancer Institute. 101, 10, p. 729-35 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The silent mutation nucleotide 744 G --> A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping

    Hansen, T. V. O., Steffensen, A. Y., Jønson, L., Andersen, M. K., Ejlertsen, Bent Laursen & Nielsen, Finn Cilius, 2009, In: Breast Cancer Research and Treatment. 119, 3, p. 547-50 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 10818876